How injectable opioid agonist treatment (iOAT) care could be improved? service providers and stakeholders’ perspectives-Reference-Cited by-同舟云学术

How injectable opioid agonist treatment (iOAT) care could be improved? service providers and stakeholders’ perspectives

Published:2023-02-07 Issue: Volume: Page:1-12
ISSN:0968-7637
Container-title:Drugs: Education, Prevention and Policy
language:en
Short-container-title:Drugs: Education, Prevention and Policy

Author:

Magel Tianna¹,Matzinger Elizabeth²,Blawatt Sarah¹²,Harrison Scott³,MacDonald Scott³,Amara Sherif⁴,Metcalfe Rebecca²,Bansback Nick¹²,Byres David⁵,Schechter Martin¹²,Oviedo-Joekes Eugenia¹²

Affiliation:

1. School of Population and Public Health, University of British Columbia, Vancouver, Canada

2. Centre for Health Evaluation & Outcome Sciences, Providence Health Care, St. Paul’s Hospital, Vancouver, Canada

3. Providence Health Care, Providence Crosstown Clinic, Vancouver, Canada

4. SafePoint Supervised Consumption Site, Fraser Health Authority, Surrey, Canada

5. Provincial Health Services Authority, Vancouver, Canada

Funder

Canadian Institutes of Health Research

Canada Research Chairs Program

Publisher

Informa UK Limited

Subject

Health (social science),Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/09687637.2023.2176287

Reference69 articles.

1. American Society of Addiction Medicine (2019). The ASAM national practice guideline for the treatment of opioid use disorder: 2020 Focused Update. Lippincott Williams & Wilkins. https://doi.org/10.197/ADM.0000000000000633

2. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial

3. BC Coroners Service (2022). Illicit drug toxicity deaths in BC January 1, 2012- September 30, 2022. https://www2.gov.bc.ca/gov/content/life-

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Client preferences for the design and delivery of injectable opioid agonist treatment services: Results from a best–worst scaling task;Addiction;2024-07-25

2. “If it wasn’t for them, I don’t think I would be here”: experiences of the first year of a safer supply program during the dual public health emergencies of COVID-19 and the drug toxicity crisis;Harm Reduction Journal;2024-06-07

3. Shared decision-making and client-reported dose satisfaction in a longitudinal cohort receiving injectable opioid agonist treatment (iOAT);Substance Abuse Treatment, Prevention, and Policy;2024-01-03

4. Experiences of serious depression and serious anxiety among individuals receiving injectable opioid agonist treatment (iOAT);Journal of Affective Disorders Reports;2024-01

5. “It feels like I’m coming to a friend’s house”: an interpretive descriptive study of an integrated care site offering iOAT (Dr. Peter Centre);Addiction Science & Clinical Practice;2023-12-02